Published in Thromb Res on January 01, 1998
Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 4.46
Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol (2001) 1.56
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest (2003) 1.42
Dense deposit disease. Mol Immunol (2011) 1.31
Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun (2006) 1.10
Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog (2010) 1.04
Effects of extracellular DNA on plasminogen activation and fibrinolysis. J Biol Chem (2011) 0.92
Functional structure of the somatomedin B domain of vitronectin. Protein Sci (2007) 0.92
Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris. Protein Sci (2007) 0.91
Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain. J Biol Chem (2008) 0.89
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol (2011) 0.89
A BCAM0223 mutant of Burkholderia cenocepacia is deficient in hemagglutination, serum resistance, adhesion to epithelial cells and virulence. PLoS One (2012) 0.88
Human plasma protein N-glycosylation. Glycoconj J (2015) 0.88
Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA. Infect Immun (2014) 0.86
Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension. J Zhejiang Univ Sci B (2007) 0.84
Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin. PLoS One (2014) 0.84
Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex. Biochemistry (2013) 0.84
Interaction of late apoptotic and necrotic cells with vitronectin. PLoS One (2011) 0.83
Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts. Arterioscler Thromb Vasc Biol (2011) 0.82
Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia. J Bacteriol (2014) 0.80
A proteomic analysis of human follicular fluid: comparison between fertilized oocytes and non-fertilized oocytes in the same patient. J Assist Reprod Genet (2013) 0.80
Vitronectin expression in the airways of subjects with asthma and chronic obstructive pulmonary disease. PLoS One (2015) 0.80
Complement Evasion by Pathogenic Leptospira. Front Immunol (2016) 0.78
Identification and therapeutic potential of a vitronectin binding region of meningococcal msf. PLoS One (2015) 0.76
Vitronectin significantly influences prognosis in osteosarcoma. Int J Clin Exp Pathol (2015) 0.75
Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease. J Cardiovasc Thorac Res (2015) 0.75
Molecular Aspects of Wound Healing and the Rise of Venous Leg Ulceration: Omics Approaches to Enhance Knowledge and Aid Diagnostic Discovery. Clin Biochem Rev (2017) 0.75
Surgical diverticulitis is not associated with defects in the expression of wound healing genes. Int J Colorectal Dis (2015) 0.75
Bacteriophage-T7-induced DNA-priming protein. A novel enzyme involved in DNA replication. Eur J Biochem (1977) 1.69
Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab (2001) 1.37
DNA scission after focal brain ischemia. Temporal differences in two species. Stroke (1997) 1.11
Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest (1995) 1.00
Regulation of plasminogen gene expression by interleukin-6. Blood (1997) 0.90
Studies on bacteriophage T7 DNA synthesis in vitro. I. Resolution of the T7 replication system into its components. Mol Gen Genet (1975) 0.88
Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochem Cell Biol (1997) 0.87
The PAI-1/vitronectin interaction: two cats in a bag? Thromb Haemost (1995) 0.85
Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis. Br Heart J (1988) 0.85
Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms. Am J Pathol (1998) 0.83
Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. J Biol Chem (1990) 0.82
Accumulation of type 1 plasminogen activator inhibitor and vitronectin at sites of cellular necrosis and inflammation. Ann N Y Acad Sci (1992) 0.82
Characterization of the denaturation and renaturation of human plasma vitronectin. II. Investigation into the mechanism of formation of multimers. J Biol Chem (1996) 0.82
Oxidative stress-inducible protein tyrosine phosphatase in glomerulonephritis. Kidney Int (1995) 0.79
Progress towards testing the amyloid hypothesis: inhibitors of APP processing. Curr Opin Drug Discov Devel (2001) 0.77
A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectin. Anal Biochem (2001) 0.76
Medical control of abdominal aortic aneurysm expansion rate. J Vasc Surg (1996) 0.75
Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells. Blood (1993) 0.75
Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. Thromb Res (1992) 0.75
[Effect of protein content and thyroid hormone on body composition in growing rats]. Nahrung (1977) 0.75
Abnormalities in the fibrinolytic system of the vascular wall associated with atherosclerosis. Ann N Y Acad Sci (1995) 0.75